NCT02320045View on ClinicalTrials.gov

Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Renal Insufficiency
Interventions
DRUG

ITCA 650 (Exenatide in osmotic mini pump)

Trial Locations (4)

02210

Intarcia Therapeutics Inc., Boston

Unknown

Study Site, Kiel

Study Site, Mannheim

Study Site, Mönchengladbach

Sponsors
All Listed Sponsors
lead

Intarcia Therapeutics

INDUSTRY